SR ONE CAPITAL MANAGEMENT, LP Q4 2021 Filing

Filed February 14, 2022

Portfolio Value

$176.9B

Holdings

2

Report Date

Q4 2021

Filing Type

13F-HR

All Holdings (2 positions)

#StockSharesValue% PortfolioType
1
DSGNDESIGN THERAPEUTICS INC
5,626,476$120.5B68.08%
2
EFTREFFECTOR THERAPEUTICS INC
6,822,114$56.5B31.92%